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Abstract
The taxonomic classification of 182 phenotypically similar isolates was evaluated using DNA–
DNA hybridization and 16S rRNA gene sequence analysis. These bacterial isolates were mainly 
derived from clinical sources; all were Gram-negative non-fermenters and most were 
indoleproducing. Phenotypically, they resembled species from the genera Chryseobacterium, 
Elizabethkingia or Empedobacter or belonged to CDC groups IIc, IIe, IIh and IIi. Based on these 
analyses, four novel species are described: Chryseobacterium bernardetii sp. nov. (type strain 
NCTC 13530T=CCUG 60564T=CDC G229T), Chryseobacterium carnis sp. nov. (type strain 
NCTC 13525T=CCUG 60559T=CDC G81T), Chryseobacterium lactis sp. nov. (type strain NCTC 
11390T=CCUG 60566T=CDC KC1864T) and Chryseobacterium nakagawai sp. nov. (type strain 
NCTC 13529T=CCUG 60563T=CDC G41T). The new combination Chryseobacterium 
taklimakanense comb. nov. (type strain NCTC 13490T=X-65T=CCTCC AB 208154T=NRRL 
B-51322T) is also proposed to accommodate the reclassified Planobacterium taklimakanense.
INTRODUCTION
Phenotypically similar bacteria belonging to the family Flavobacteriaceae have long been 
recognized as genetically diverse. Sottile et al. (1973) noted high levels of nucleotide 
sequence divergence within the species Flavobacterium meningosepticum (now 
Elizabethkingia meningoseptica) compared with the type strain of F. meningosepticum, 
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NCTC 10016T, and Owen & Snell (1976) showed that the type strain shared on average 
only 30% of its DNA sequence with most other strains of F. meningosepticum, including 
strains of the same serotype. Another reference strain proved to be highly related to all the 
other strains, confirming the atypical nature of the type strain. Subsequently, Ursing & 
Bruun (1987) studied DNA reassociation in 52 strains of F. meningosepticum and found two 
main hybridization groups that were about 40–55% interrelated and comprised four and 48 
strains, respectively. The larger group could be divided further into four subgroups if 
differences in thermal stability of reassociated duplexes were taken into consideration.
Owen & Holmes (1980) studied ten strains that had been identified as Flavobacterium breve 
(now Empedobacter brevis) and found that six had high levels of intraspecific nucleotide 
sequence similarity, whilst the other four contained a high degree of nucleotide sequence 
divergence. Amongst clinically important members of the genus Flavobacterium, as the 
genus was defined at the time, four natural phenotypic groups were discerned (Holmes & 
Owen, 1981). Group A comprised saccharolytic, proteolytic, mostly indole-producing 
strains (now assigned to the genera Chryseobacterium, Elizabethkingia and Empedobacter; 
see Vandamme et al., 1994). Group B comprised non-saccharolytic, proteolytic, non-indole-
producing strains (now assigned to Myroides). Group C comprised saccharolytic, non-
actively proteolytic, non-indole-producing strains (now assigned to Sphingobacterium). 
Group D was less like Flavobacterium and comprised non-saccharolytic, proteolytic, indole-
producing strains, but which were not yellow-pigmented and were more susceptible to 
antimicrobial agents (now assigned to Bergeyella and Weeksella).
Owen & Holmes (1981) also described a relatively broad range of G+C contents in 
Flavobacterium odoratum (which was reflected in DNA–DNA hybridizations and which 
later led to a division into Myroides odoratus and Myroides odoratimimus) and CDC group 
IIb (which was also reflected in DNA–DNA hybridizations). Subsequently, Ursing & Bruun 
(1991) investigated DNA reassociation in 42 strains presumptively identified as belonging to 
F. breve or to CDC group IIb. F. breve was found to constitute two genomic groups (approx. 
45% interrelated) comprising eight and three strains, respectively. Strains of CDC group IIb 
demonstrated great genomic diversity, with Flavobacterium gleum and Flavobacterium 
indologenes (now Chryseobacterium gleum and Chryseobacterium indologenes) constituting 
the largest groups, with nine and 11 strains, respectively. The presumably related CDC 
groups IIc, IIe, IIh and IIi (Weyant et al., 1995) were also usually indole-producing, but 
remained unnamed. The present study was undertaken to resolve the taxonomic position of 
strains representing the four latter unnamed groups.
METHODS
Details of the strains examined in the present study are given in Table 1. An additional 15 
strains were examined, but are not described in this paper as they could not be assigned to 
any group.
The methods used for the extraction and purification of DNA from the strains studied and 
the hydroxyapatite hybridization method for determining levels of DNA relatedness between 
them have been described previously (Brenner et al., 1982). Since the optimal temperature 
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for DNA reassociation is Tm0230 °C (Tm−215 °C for the stringent condition), and members 
of the family Flavobacteriaceae have a lower G+C content than members of the family 
Enterobacteriaceae, the temperatures used in this study were slightly lower than those used 
by Brenner et al. (1982). Reference DNAs were labelled enzymatically in vitro with 
[32P]dCTP by using a nick translation reagent kit (Invitrogen), as directed by the 
manufacturer. DNA hybridization tests were performed in duplicate at 55 °C and in some 
cases also at 70 °C. Percentage divergence was calculated to the nearest 0.5%.
For DNA extraction and 16S rRNA gene sequencing, colonies were removed from a culture 
plate using a 1 μl loop, suspended in 200 μl DMSO and incubated at room temperature for 
30 min. The 16S rRNA gene was amplified from the DNA suspension by using the Expand 
High-Fidelity PCR system (Roche Diagnostics). An aliquot of 2.5 μl DNA suspension was 
used as template in a 50 μl PCR mix containing 2.5 U polymerase, 1.5 mM MgCl2, 200 μM 
dNTPs and 400 nM primers fD1 and rP2 in order to amplify the gene from nucleotide 
positions 8 to 1492 of the Escherichia coli 16S rRNA gene (GenBank accession no. 
J01695). The PCR primer sequences are from Weisburg et al. (1991).
Amplification was performed on an ABI 9700 thermocycler (Applied Biosystems) using a 
program of 94 °C for 5 min followed by 35 cycles of 94 °C for 15 s, 50 °C for 15 s and 72 
°C for 90 s, with a final single extension of 72 °C for 5 min, and then held at 4 °C. 
Amplified products were examined by electrophoresis of 5 μl of each reaction on a 1.2% 
agarose e-gel (Invitrogen) for 30 min at 85 V. Excess nucleotides and primers were removed 
using a QIAquick PCR Purification kit (Qiagen). The purified PCR product was used as a 
template in 20 μl cycle sequencing reactions with Big Dye version 3.1 (Applied 
Biosystems). Sixteen sequencing primers were used, as listed in Table S1 (available in 
IJSEM Online). Primer sequences beginning with BSF or BSR are from the European rRNA 
database (http://bioinformatics.psb.ugent.be/webtools/rRNA/), primer sequences named 
R357 and R519 are from Stackebrandt & Charfreitag (1990) and fD1 is from Weisburg et al. 
(1991), F357, F530, and R530 are from Sacchi et al. (2002), and fD1-5p, F785, R802, and 
rP2-5p are from Morey et al. (2006). Sequencing reaction products were purified with 
Centri-Sep plates (Princeton Separations). Reactions were electrophoresed on an ABI 3130 
or 3730 system using POP-7 polymer (Applied Biosystems). Chromatograms were 
assembled and analysed in Seqmerge (Wisconsin package version 10.3; Accelrys).
Phylogenetic and molecular evolutionary analyses were conducted using BioEdit (Hall, 
1999) and CLUSTAL X2 (Larkin et al., 2007). Alignments were corrected manually where 
necessary, and end-trimming was performed so that percentage identities between 16S 
rRNA gene sequences were calculated over the range shared by both sequences. Trees were 
visualized using MEGA version 4 (Tamura et al., 2007).
All strains were characterized biochemically in all or most of a range of 68 conventional 
biochemical tests by methods described previously (Holmes et al., 1975).
RESULTS AND DISCUSSION
The DNA–DNA hybridization results are presented in Tables 2, 3, 4, 5 and 6, and published 
names of the various genomic groups are summarized in Table 7. Strains representing 
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species of the genera Empedobacter, Elizabethkingia and Sphingobacterium will be 
discussed first, roughly in the order in which they appear in Tables 2, 3, 4, 5 and 6, followed 
by strains representing known species of the genera Chryseobacterium and Flavobacterium. 
Novel Chryseobacterium species will then be discussed in alphabetical order.
Fourteen strains could be ascribed to Empedobacter brevis, as they showed high levels of 
DNA–DNA relatedness (69–82%) to the type strain (Table 2). These included the six strains 
studied by Owen & Holmes (1980) found to have high levels of intraspecific nucleotide 
sequence similarity (>70%). Four other strains from that study, which were identified 
biochemically as Empedobacter brevis, proved only 35–42% related, and these were 
distributed over different groups in the present study; ATCC 14234 and CL 94/78 together 
formed the 92 group (Table 5), NCTC 11163 was a member of the large 58 group (Table 3), 
whilst CL93/78 (data not shown) remained one of the 15 lone strains.
The 16S rRNA gene sequence of ATCC 14234, representing the two strains of the 92 group 
(Table 5), was >99.9% similar to that of Empedobacter brevis LMG 4011T (GenBank 
accession no. AM177497). Stackebrandt & Ebers (2006) proposed that a 16S rRNA gene 
sequence similarity above 98.7–99% should be mandatory for testing the genomic 
uniqueness of a novel isolate. Ursing & Bruun (1991) found that DNA–DNA hybridization 
of ATCC 14234 showed a reassociation of >70% with the type strain of Empedobacter 
brevis (NCTC 11099T), but Owen & Holmes (1980) and the present study (Table 2) found 
only 35–48 and 34–45% relatedness, respectively, to the type strain of Empedobacter brevis. 
No direct comparison of the isolates used by each group has been made, so none of the 
possible reasons for this discrepancy (such as differences in technique or a mix-up of 
strains) have been ruled out. Although indistinguishable in biochemical tests and in 16S 
rRNA gene sequence similarity, strains in this group may represent separate genomospecies. 
Strain 92 (=ATCC 14234) has been preserved as NCTC 13469 to represent ‘Empedobacter 
brevis-like species 1’.
Elizabethkingia meningoseptica is a complex of several genomic groups (Sottile et al., 1973; 
Owen & Snell, 1976; Ursing & Bruun, 1987). Many cultures from these previous studies 
were included in the present study, and the DNA–DNA hybridization results (Table 4) 
support these earlier findings. Only two strains in this study were found to show high levels 
of DNA–DNA relatedness (82–87%) to the type strain (Table 5), confirming the findings of 
Ursing & Bruun (1987). In view of the rarity of such strains, strain 256 has been preserved 
as NCTC 13393. In this study, the 245 group comprised five strains and corresponded to 
Ursing and Bruun group II: 1 (Table 4), the 251 group comprised three strains and 
corresponded to Ursing and Bruun group II: 2 (Table 4), the 255 group comprised six strains 
and corresponded to Ursing and Bruun group II: 3 (Table 4), whilst the 259 group comprised 
three strains and corresponded to Ursing and Bruun group II: 4 (Table 6). Many strains in 
the present study were included in that of Ursing & Bruun (1987), and all were assigned to 
the same groups they described. DNA–DNA hybridization levels above 70% between 
groups were seen (Table 4) between the 251 and 255 groups, 251 and 259 groups and 255 
and 259 groups, but with a divergence in related sequences ≥4.0%. No characters to 
differentiate these genomic groups have yet been found, so they remain assigned for the time 
being to Elizabethkingia meningoseptica.
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The 16S rRNA gene sequence of CDC E8371, representing the two strains of the 231 group 
(Table 4), was 99.9% identical to that of Sphingobacterium daejeonense TR6-04T (GenBank 
accession no. AB249372), suggesting that the 231 group can be assigned to this species, 
which was confirmed by a DNA–DNA relatedness value of 80% between the two (Table 8). 
The species was originally described to accommodate a single strain isolated from compost, 
but the members of this taxon identified in this study were both from human clinical 
sources. Both were also representatives of CDC group IIi, so the assignment of these two 
strains to this genus would be unexpected. Given the paucity of isolates of this species and 
the fact that the isolates identified in this study are the first to be recognized from clinical 
sources, CDC E8371 has been preserved as NCTC 13534 and CL714/92 as NCTC 13522.
The 16S rRNA gene sequence of CDC F859, representing the two strains of the 217 group 
(Table 4), was 99.8% identical to that of Sphingobacterium lactis DSM 22361T (GenBank 
accession no. FN908501). These two strains were phenotypically similar to the strain 
description of S. lactis (Schmidt et al., 2012), except that they grew on MacConkey agar and 
did not produce DNase. Strain CDC F859 had a DNA G + C content of 39.5 mol%, as 
opposed to the 44.2 mol% reported in the species description. Despite these phenotypic 
variations, CDC F859 is presumed to represent S. lactis, and has been preserved as NCTC 
135265CCUG 60560.
Fifteen strains could be ascribed to Chryseobacterium indologenes, as they showed high 
levels of DNA–DNA relatedness (80–96%) to its type strain (Table 2). A single strain of 
Chryseobacterium gleum was identified (CL424/73, which showed 80% DNA–DNA 
relatedness to the type strain of C. gleum; Table 2) and can be added to the 12 identified in 
the original description of the species (Holmes et al., 1984) and to the additional four found 
by Ursing & Bruun (1991). No additional strains of Chryseobacterium balustinum were 
found in this study to show high levels of DNA–DNA relatedness to the type strain, but two 
more strains of Chryseobacterium indoltheticum, from environmental sources, were 
identified (Table 2), as they showed 76–82% DNA–DNA relatedness to the type strain. 
Given the paucity of isolates of this species, CL743/78 has been preserved as NCTC 13532.
The 16S rRNA gene sequence of CL311/80, representing the 12 strains of the 93 group 
(Table 3), was 99.3% identical to that of Chryseobacterium anthropi NF 1366T (GenBank 
accession no. AM982786), suggesting that the 93 group can be assigned to this species. This 
species assignment was confirmed by the fact that Kämpfer et al. (2009b), when describing 
the novel species, included in their study CDC F4391, which was also included in the 
present study. The species was originally described to accommodate eight strains of human 
clinical origin. Most of the strains identified in this study were similarly from human clinical 
specimens, but two were from a veterinary source and one from chiller water associated with 
poultry processing. CL311/80 has been preserved as NCTC 135285CCUG 60562.
The 16S rRNA gene sequence of CDC F5649, representing the 19 strains of the 224 group 
(Table 3), was 99.9% identical to that of Chryseobacterium hominis NF802T (GenBank 
accession no. AM261868), suggesting that the 224 group can be assigned to this species. 
This species assignment was confirmed by a DNA–DNA relatedness value of 96% between 
the two (Table 9). The species was originally described to accommodate clinical isolates 
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biochemically similar to CDC groups IIc and IIh. The members of this taxon identified in 
this study included several representatives of CDC groups IIc and IIh and were all from 
human clinical sources.
The 16S rRNA gene sequence of CL712/92, representing the four strains of the 212 group 
(Table 3), was 99.7% identical to that of Planobacterium taklimakanense X-65T (GenBank 
accession no. EU718058) and 95.4% identical to that of Chryseobacterium haifense H38T 
(EF204450), suggesting that the 212 group might have affinities to these species. P. 
taklimakanense was originally described to accommodate a single strain from desert soil 
(Peng et al., 2009), and C. haifense was originally described as a psychrotolerant bacterium 
isolated from raw milk (Hantsis-Zacharov & Halpern, 2007), whereas the strains comprising 
the 212 group contained representatives of CDC groups IIc and IIe and all were from human 
clinical sources. However, any possible close relationship of the 212 group to C. haifense 
was not confirmed by DNA–DNA relatedness, with a value of only 18% between the two 
(Table 9). The four strains of the 212 group appear to correspond to P. taklimakanense, 
differing from the species description only in that they were non-motile in broth. CL712/92 
has been preserved as NCTC 135275CCUG 60561. Fig. 1 includes species of the genus 
Chryseobacterium published after the initial description of P. taklimakanense, which clearly 
falls in the Chryseobacterium clade. There is no longer any justification for Planobacterium 
as a separate genus, and the new combination Chryseobacterium taklimakanense comb. nov. 
is formally proposed.
The 16S rRNA gene sequence of A86/68, representing the two strains of the 123 group 
(Table 6), was 99.3% identical to that of Chryseobacterium ureilyticum F-Fue-04IIIaaaaT 
(GenBank accession no. AM232806) and 98.4% identical to that of Chryseobacterium 
joostei LMG 18212T (AJ271010), suggesting that the 123 group can be assigned to the 
former species. Any possible close relationship to C. joostei was not confirmed by DNA–
DNA relatedness, with a value of only 55% between the two (Table 9). C. ureilyticum was 
originally described to accommodate a single strain associated with a beer-bottling plant, 
whilst C. joostei was originally described to accommodate strains isolated from the dairy 
environment. The two strains identified in this study, however, were from human clinical 
specimens. A86/68 has been preserved as NCTC 135245CCUG 60558.
The 16S rRNA gene sequence of A104/68, representing the two strains of the 125 group 
(Table 6), was 98.9% identical to that of Chryseobacterium shigense GUM-KajiT (GenBank 
accession no. AB193101), suggesting that the 125 group can be assigned to this species, 
which was confirmed by a DNA–DNA relatedness value of 77% between the two (Table 9). 
The species was originally described to accommodate a single strain isolated from a lactic 
acid beverage, and the members of this taxon identified in this study were both from milk 
swabs. Given the paucity of isolates of this species, A104/68 has been preserved as NCTC 
13533.
The 16S rRNA gene sequence of CL479/77, representing the three strains of the 71 group, 
was 98.6% identical to that of Chryseobacterium gleum CCUG 14555T (GenBank accession 
no. AM232812). Although suggesting that the 71 group might have some affinity to this 
species, DNA–DNA hybridization results from the present study revealed only 43–65% 
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relatedness (with a divergence in related sequences >9.0%; Table 2) to the type strain of C. 
gleum. Thus, despite showing high 16S rRNA gene sequence similarity, these three strains 
clearly form a distinct and homogeneous taxon.
The 16S rRNA gene sequence of CL88/78, representing the two strains of the 95 group, was 
98.4% identical to that of Chryseobacterium (Sejongia) jeonii AT1047T (GenBank 
accession no. AY553294), suggesting that the 95 group might have an affinity to this 
species. However, any possible close relationship was not confirmed by DNA–DNA 
relatedness, with a value of only 20% between the two (Table 8). The species was originally 
described to accommodate a single strain isolated from an Antarctic terrestrial sample; both 
members of the 95 group were from meat.
The 16S rRNA gene sequence of CL636/74, representing the two strains of the 137 group 
(Table 6), was 99.4% identical to that of Flavobacterium lindanitolerans IP-10T (GenBank 
accession no. EF424395), suggesting that the 137 group can be assigned to this species. The 
species was originally described to accommodate a single strain from soil, whereas both 
strains identified in this study were from human clinical specimens. CL636/74 has been 
preserved as NCTC 13531=CCUG 60565.
The 16S rRNA gene sequence of strains representing the remaining four groups (58 group, 
48 strains; 142 group, six strains; 63 group, two strains; and 78 group, two strains) did not 
show high levels of similarity to the type strains of any other named taxa in the GenBank 
database, suggesting they represent hitherto unnamed taxa. However, the 16S rRNA gene 
sequence of NCTC 11310, representing the 48 strains of the 58 group, was >99.9% similar 
to a strain of Wautersiella falsenii genomovar 2 (GenBank accession no. AM238678), 
suggesting that the 58 group might correspond to this hitherto-unnamed but phenotypically 
indistinguishable genomic species. Since W. falsenii was described to accommodate clinical 
isolates phenotypically resembling members of the genera Chryseobacterium and 
Empedobacter and CDC group IIh, and given that several of the strains of the 58 group were 
deposited as reference strains of F. meningosepticum serotypes (see, for example, Richard et 
al., 1979) whilst one was of CDC group IIh, such a relationship was perfectly feasible. The 
synonymy of the 58 group with W. falsenii was confirmed by DNA–DNA relatedness values 
of ≥85% between the 58 group and the two biovars (Table 8).
Overall, five groups (71 group, three strains; 95 group, two strains; 142 group, six strains; 63 
group, two strains; and 78 group, two strains) each constituted novel genomospecies of the 
genus Chryseobacterium. To determine their phylogenetic positions, a phylogenetic tree of 
all species of Chryseobacterium was reconstructed (Fig. S1). Although the 16S rRNA gene 
sequence of CL479/77, representing the three strains of the 71 group, fell in the same clade 
as that of the type strain of C. gleum, DNA–DNA hybridization results did not confirm these 
strains as members of C. gleum. This group is therefore clearly a candidate novel species, 
but no phenotypic differences from C. gleum could be found, so it is not appropriate to 
propose the 71 group as a novel species at this time. Strain 71 (CL479/77) has been 
preserved as NCTC 13470 to represent ‘C. gleum-like species 1’. The type strains of the 
nearest neighbours of each of the remaining four groups were then characterized to identify 
characteristics that might differentiate each from its nearest neighbours. These differential 
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characteristics are displayed in Tables 10 and 11. On the basis of the 16S rRNA gene 
sequence of strains and the differential phenotypic characters, four novel species are 
proposed.
Although strains of CDC groups IIc, IIe, IIh and IIi were so assigned on the basis of 
phenotypic characters, there was little correlation with genomic data, as members of each 
group belonged to at least two different DNA–DNA hybridization groups as defined in this 
study (three in the case of CDC group IIi), or proved to be single isolates. The 93 group, 
however, was composed almost entirely of strains of or resembling CDC group IIe. The 
disposition of the various groups identified in this study and their correlation to the CDC 
phenotypic groups are summarized in Table 7. Fifteen strains (including CL93/78) were the 
sole representative of their groups, and it is likely that some of these represent novel taxa, 
but only those groups containing at least two representatives are described here.
The novel species Chryseobacterium bernardetii and Chryseobacterium nakagawai were 
both derived from clinical samples and share a set of near-neighbours that includes C. 
indologenes (Fig. 2), which is a known human pathogen (Chen et al., 2013). The possibility 
that this cluster of species of Chryseobacterium shares virulence characteristics remains to 
be investigated.
Description of Chryseobacterium taklimakanense comb. nov
Chryseobacterium taklimakanense (tak.li.ma.kan.en′se. N.L. neut. adj. taklimakanense 
pertaining to the desert of Taklimakan,Xinjiang,China,wherethetypestrainwasisolated).
Basonym: Planobacterium taklimakanense Peng et al. 2009.
The description is that of Peng et al. (2009). The type strain is X-65T=CCTCC AB 
208154T=NRRL B-51322T=NCTC 13490T.
Description of Chryseobacterium bernardetii sp. nov
Chryseobacterium bernardetii (ber.nar.de′ti.i. N.L. masc. gen. n. bernardetii of Bernardet, 
named after Jean-François Bernardet, a French microbiologist long associated with this 
group of organisms).
Described in this study based on six strains comprising the 142 group. Cells are Gram-
negative. Colonies are circular, convex, entire, opaque, shiny, smooth and yellow-
pigmented. Positive for acid production (in ammonium salt medium) from glucose, 
arabinose, fructose, glycerol, maltose, sucrose and trehalose, aesculin hydrolysis, casein 
digestion, catalase production, cytochrome oxidase production, gelatinase production (stab 
method), growth at 37 °C, at room temperature (18–22 °C), on MacConkey agar and on β-
hydroxybutyrate, hydrolysis of tyrosine, oxidative metabolism in Hugh and Leifson O-F test 
(one strain positive only after incubation for more than 5 days) and production of brown 
melanin-like pigment on tyrosine agar. Negative for acid production (in ammonium salt 
medium) from adonitol, cellobiose, dulcitol, ethanol, inositol, lactose, mannitol, raffinose, 
rhamnose, salicin and sorbitol, acid and gas production from glucose in peptone water 
medium, acid from 10% (w/v) lactose, arginine dihydrolase production, fluorescence on 
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King’s B medium, gluconate oxidation, growth at 5 °C and on cetrimide agar, H2S 
production (by both lead acetate paper and triple-sugar iron agar methods), KCN tolerance, 
lipid inclusions after growth on β-hydroxybutyrate, lysine decarboxylase production, 
malonate utilization, motility (hanging drop preparation at both 37 °C and room 
temperature), nitrate reduction, ornithine decarboxylase production, phenylalanine 
deamination, reduction of 0.4% (w/v) selenite, utilization of citrate (Simmons’ medium), β-
galactosidase production (ONPG test) and 3-ketolactose production. The six strains studied 
differ in the following tests (result in parentheses for the type strain): acid production (in 
ammonium salt medium) from xylose (+), acid from 10% (w/v) glucose (+), gelatinase 
production (plate method; +), growth at 42 °C (+), hydrolysis of Tween 20 (+), Tween 80 
(−) and starch (−), lecithinase production (−), nitrite reduction (+), production of 
extracellular DNase (+), urease production (−) and utilization of citrate (Christensen’s 
medium; +). Phenotypic characteristics (between one and four in number) useful for the 
differentiation of C. bernardetii (142 group) from its nearest neighbours are shown in Table 
10. Only the inability to grow at 5 °C distinguishes C. bernardetii from C. joostei.
The G+C content of the type strain is 37.0 mol%. The type strain is NCTC 13530T=CCUG 
60564T=CL318/82T=CDC G229T; it was isolated from sputum in Doncaster, UK.
Description of Chryseobacterium carnis sp. nov
Chryseobacterium carnis (car′nis. L. gen. n. carnis of flesh).
Described in this study based on two strains comprising the 95 group. Cells are Gram-
negative. Colonies are circular, convex, entire, opaque, shiny, smooth and yellow-
pigmented. Positive for acid production (in ammonium salt medium) from glucose and 
maltose, casein digestion, catalase production, cytochrome oxidase production, gelatinase 
production (plate and stab methods), growth at 37 °C, at room temperature (18–22 °C), on β-
hydroxybutyrate and on MacConkey agar, hydrolysis of starch and Tween 20 and 
production of extracellular DNase. Negative for acid production (in ammonium salt 
medium) from adonitol, arabinose, cellobiose, dulcitol, ethanol, fructose, glycerol, inositol, 
lactose, mannitol, raffinose, rhamnose, salicin, sorbitol, sucrose, trehalose and xylose, acid 
from 10% (w/v) glucose and from 10% (w/v) lactose, aesculin hydrolysis, arginine 
dihydrolase production, fluorescence on King’s B medium, gas production from glucose in 
peptone water medium, gluconate oxidation, growth at 42 °C and on cetrimide agar, Hugh 
and Leifson O-F test, hydrolysis of Tween 80 and tyrosine, H2S production (by both lead 
acetate paper and triple-sugar iron agar methods), lecithinase production, lipid inclusions 
after growth on β-hydroxybutyrate, lysine decarboxylase production, malonate utilization, 
motility (hanging drop preparation at both 37 °C and room temperature), nitrate reduction, 
nitrite reduction, ornithine decarboxylase production, phenylalanine deamination, 
production of brown melanin-like pigment on tyrosine agar, reduction of 0.4% (w/v) 
selenite, urease production, utilization of citrate (Christensen’s and Simmons’ media), β-
galactosidase production (ONPG test) and 3-ketolactose production. The two strains studied 
differ in the following tests (type strain positive): acid production from glucose in peptone 
water medium, growth at 5 °C and KCN tolerance. Phenotypic characteristics (between 
three and 10 in number) useful for the differentiation of C. carnis (95 group) from its nearest 
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neighbours, several of which were originally described as belonging to the genus Sejongia, 
are shown in Table 11. The assertion that species of the genus Sejongia be transferred to the 
genus Chryseobacterium (Kämpfer et al., 2009a) was supported (Fig. 3), so this novel 
species is assigned to the genus Chryseobacterium.
The G + C content of the type strain is 34.0 mol%. The type strain is NCTC 13525T=CCUG 
60559T=CL88/78T=Hayes B19/1T=CDC G81T; it was isolated from beef.
Description of Chryseobacterium lactis sp. nov
Chryseobacterium lactis (lac′tis. L. gen. n. lactis of/from milk).
Described in this study based on two strains comprising the 63 group. Cells are Gram-
negative. Colonies are circular, convex, entire, opaque, shiny, smooth and yellow-
pigmented. Positive for acid production (in ammonium salt medium) from glucose, fructose, 
glycerol, maltose and trehalose, aesculin hydrolysis, casein digestion, catalase production, 
cytochrome oxidase production, gelatinase production (plate and stab methods), growth at 
37 °C, at room temperature (18–22 °C), on β-hydroxybutyrate and on MacConkey agar, 
hydrolysis of Tweens 20 and 80, oxidative metabolism in the Hugh and Leifson O-F test, 
production of brown melanin-like pigment on tyrosine agar and production of extracellular 
DNase. Negative for acid production (in ammonium salt medium) from adonitol, arabinose, 
cellobiose, dulcitol, ethanol, inositol, lactose, mannitol, raffinose, rhamnose, salicin, 
sorbitol, sucrose and xylose, acid and gas production from glucose in peptone water 
medium, acid from 10% (w/v) glucose and from 10% (w/v) lactose, arginine dihydrolase 
production, fluorescence on King’s B medium, gluconate oxidation, growth at 42 °C and on 
cetrimide agar, hydrolysis of starch, H2S production (by both lead acetate paper and triple-
sugar iron agar methods), KCN tolerance, lipid inclusions after growth on β-
hydroxybutyrate, lysine decarboxylase production, malonate utilization, motility (hanging 
drop preparation at both 37 °C and room temperature), nitrate reduction, nitrite reduction, 
ornithine decarboxylase production, phenylalanine deamination, reduction of 0.4% (w/v) 
selenite, urease production, utilization of citrate (Christensen’s and Simmons’ media), β-
galactosidase production (ONPG test) and 3-ketolactose production. The two strains studied 
differ in the following tests (type strain positive): growth at 5 °C, hydrolysis of tyrosine and 
lecithinase production. Phenotypic characteristics (between two and five in number) useful 
for the differentiation of C. lactis (63 group) from its nearest neighbours are shown in Table 
10.
The G + C content of the type strain is 34.5 mol%. The type strain is NCTC 11390T=CCUG 
60566T=A140/68T=F68T=CDC KC1864T; it was isolated from a milk bottle rinse on a farm 
in Paisley, Scotland, UK.
Description of Chryseobacterium nakagawai sp. nov
Chryseobacterium nakagawai (na.ka.ga′wa.i. N.L. masc. gen. n. nakagawai of Nakagawa, 
named after Yasuyoshi Nakagawa, a Japanese microbiologist long associated with this 
group of organisms).
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Described in this study based on two strains comprising the 78 group. Cells are Gram-
negative. Colonies are circular, convex, entire, opaque, shiny, smooth and yellow-
pigmented. Positive for acid production (in ammonium salt medium) from glucose, maltose 
and trehalose, casein digestion, catalase production, cytochrome oxidase production, 
gelatinase production (plate and stab methods), growth at 37 °C, at room temperature (18–22 
°C) and on β-hydroxybutyrate, hydrolysis of starch, Tween 20 and tyrosine, lecithinase 
production, oxidative metabolism in Hugh and Leifson O-F test, production of brown 
melanin-like pigment on tyrosine agar and production of extracellular DNase. Negative for 
acid production (in ammonium salt medium) from adonitol, arabinose, cellobiose, dulcitol, 
ethanol, fructose, inositol, lactose, mannitol, raffinose, rhamnose, salicin, sorbitol, sucrose 
and xylose, acid and gas production from glucose in peptone water medium, acid from 10% 
(w/v) glucose and 10% (w/v) lactose, arginine dihydrolase production, fluorescence on 
King’s B medium, gluconate oxidation, growth at 5 and 42 °C and on MacConkey agar, H2S 
production (by both lead acetate paper and triple-sugar iron agar methods), KCN tolerance, 
lipid inclusions after growth on β-hydroxybutyrate, lysine decarboxylase production, 
malonate utilization, motility (hanging drop preparation at both 37 °C and room 
temperature), nitrate reduction, nitrite reduction, ornithine decarboxylase production, 
phenylalanine deamination, reduction of 0.4% (w/v) selenite, urease production, utilization 
of citrate (Simmons’ medium), β-galactosidase production (ONPG test) and 3-ketolactose 
production. The two strains studied differ in the following tests (type strain positive): acid 
production (in ammonium salt medium) from glycerol, aesculin hydrolysis, growth on 
cetrimide agar, hydrolysis of Tween 80 and utilization of citrate (Christensen’s medium). 
Phenotypic characteristics (between three and five in number) useful for the differentiation 
of C. nakagawai (78 group) from its nearest neighbours are shown in Table 10.
The G + C content of the type strain is 35.0 mol%. The type strain is NCTC 13529T=CCUG 
60563T=F91T=CDC G41T; it was isolated from a kidney abscess in Gloucester, UK.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Neighbour-joining phylogenetic tree showing the relationships of 16S rRNA gene sequences 
from the type strains of Chryseobacterium bernardetii sp. nov., Chryseobacterium carnis sp. 
nov., Chryseobacterium lactis sp. nov. and Chryseobacterium nakagawai sp. nov. with 
sequences of the type strains of all other species of the genus Chryseobacterium. The tree is 
rooted, with Weeksella virosa ATCC 43766T as the outgroup (not shown; GenBank 
accession no. M93152). GenBank accession numbers are given in parentheses. Bootstrap 
support from 1000 resamplings at nodes is displayed as percentages. Bar, 0.005 substitutions 
per nucleotide position. Strains described in this study are highlighted in bold. Full-length 
sequences were not available for all strains, so the alignment was trimmed to the 1336 bp for 
which data were available for all strains. The full tree is available as Fig. S1. Shown here is 
the node of the tree that supports the assertion that the species named Planobacterium 
taklimakanense is actually a species of Chryseobacterium.
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Fig. 2. 
Three of the newly identified Chryseobacterium species, which were derived from clinical 
specimens, belong to a cluster of species that includes the known human pathogen C. 
indologenes. The rooted tree was generated using the same parameters as described for Fig. 
1, but an additional 111 bp was available for all of the selected strains, and was included in 
the alignment. The tree included all 16S rRNA gene sequence data that were available for all 
of the selected strains.
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Fig. 3. 
This analysis supports the suggestion that species of the genus Sejongia be transferred to the 
genus Chryseobacterium. As with Fig. 2, this analysis was done using the parameters 
described in Fig. 1.
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Table 1
Designation and source of strains studied
Culture numbers prefixed by the letters A, F or CL are strains received for identification at the NCTC. NCTC, 
National Collection of Type Cultures, Health Protection Agency, Colindale, London, UK;
Strain Other strain designation(s) Source
Chryseobacterium indologenes (16 strains)
 50T NCTC 10796T=CDC KC1854T=CDC 3716T Trachea at autopsy; unknown
 65 CL361/70=F142=CDC F9967 Respirator; London, UK
 67 CL471/75=CDC F9969 Nasal swab; Dublin, Ireland
 68 CL45/78=CDC F9970 Urine; London, UK
 70 CL44/78=CDC F9972 Catheter urine; London, UK
 74 CL42/78=NCTC 11409=CDC F9976 Water; London, UK
 75 CL514/78=CDC G38 Urine; Swansea, Wales, UK
 76 CL145/70=F139=CDC G39 Blood culture; London, UK
 77 CL46/78=CDC G40 Peritoneal dialysis fluid; London, UK
 80 CL43/78=CDC G43 Catheter urine; London, UK
 116 CL9/77=CDC G161 Urine; Liverpool, UK
 124 F132=A57/70=CDC G187 Hospital kitchen surface; Northampton, UK
 141 CL223/85=CDC G228 Oral ulcer; Coventry, UK
 144 CL20/81=CDC G231 Blood; London, UK
 145 CL187/82=CDC G232 Human clinical; Birmingham, UK
 157 CL19/81=CDC G253 Blood; London, UK
Chryseobacterium gleum (2)
 51T NCTC 11432T=F93T=CDC KC1855T High vaginal swab; London, UK
 59 CL424/73=CDC F9935 Blood; Dar es Salaam, Tanzania
Chryseobacterium balustinum (1)
 62T NCTC 11212T=ATCC 33487T=CDC KC1863T Heart blood of fish; River Dordogne, France
Chryseobacterium indoltheticum (3)
 106T CL252/80T=ATCC 27950T=CDC G141T Marine mud; UK
 110 CL743/78=F32=A78/68=CDC G145 Milk sample; Paisley, Scotland, UK
 140 CL97/78=Hayes S10/1=CDC G211 Soil; unknown
Empedobacter brevis (15)
 55T NCTC 11099T=CL88/76T=CDC KC1859T Human bronchial secretion; Zurich, Switzerland
 54 NCTC 11162=CL626/75=CDC KC1858 Eye swab, human; Dublin, Ireland
 81 CL666/76=CDC G59 Urine, human; Bratislava, Slovak Republic
 83 CL42/79=CDC G61 Snake; London, UK
 87 CL478/77=CDC G65 Post-mortem lung, human; London, UK
 91 CL200/75=CDC G69 Human, unknown; London, UK
 129 F149=A93/72=CL14/79=CDC G198 Presacral abscess; London, UK
 159 CL309/80=CDC G348 Urine; Paris, France
 160 CL277/81=CDC G349 Vagina; Strasbourg, France
 161 CL476/81=Richard 6.81=CDC G350 Vagina; Strasbourg, France
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Strain Other strain designation(s) Source
 168 CL40/85=CDC G361 Umbilical artery catheter, neonate; London, UK
 183 CL167/82=Richard 19.81=CDC G376 CSF; Strasbourg, France
 190 CL624/80=CDC G383 Nasal swab, tortoise; London, UK
 191 CL297/80=CDC G384 Prairie marmot; London, UK
 211 CDC F9036 CSF; USA
58 group (48)
 58 NCTC 11310=CIP 79.30=CDC KC1862 Urine; Strasbourg, France; F. meningosepticum 
serotype L
 53 NCTC 11307=CIP 79.25=CDC KC1857 Blood culture; Strasbourg, France; F. 
meningosepticum serotype I
 56 NCTC 11163=CL669/76=CDC KC1860 Urine, human; Bratislava, Slovak Republic
 57 NCTC 11308=CIP 78.68=CDC KC1861 Skin swab; Strasbourg, France; F. meningosepticum 
serotype J
 82 CL8/74=CDC G60 Wound; Wrexham, Wales, UK
 84 CL444/73=CDC G62 Eye swab; Birmingham, UK
 85 CL452/80=CDC G63 Swan faeces; London, UK
 88 CL7/74=CDC G66 Eye; Wrexham, Wales, UK
 89 CL53/80=CDC G67 Wound; Alsace, France
 94 CL623/77=CDC G80 Blood culture; Worthing, UK
 96 CL336/80=CDC G82 Potoroo; London, UK
 99 CL540/78=CDC G99 Urine; Germany
 162 CL477/81=Richard 3.81=CDC G351 Urine; Strasbourg, France
 164 CL480/81=Richard 13.81=CDC G353 Urine; Strasbourg, France
 165 CL481/81=Richard 14.81=CDC G354 Urine; Strasbourg, France
 166 CL482/81=Richard 17.81=CDC G355 Urine; Strasbourg, France
 167 CL483/81=Richard 18.81=CDC G356 Humidifier; Strasbourg, France
 169 CL208/84=CCUG 12570=CDC G362 Unknown
 170 CL113/83=Richard 5.82=CDC G363 Throat; Strasbourg, France
 171 CL36/83=Richard 50.82=CDC G364 Urine; Strasbourg, France
 172 CL35/83=Richard 49.82=CDC G365 Urine; Strasbourg, France; F. meningosepticum 
serotype N
 173 CL 34/83=Richard 9.82=CDC G366 Vagina; Strasbourg, France; F. meningosepticum 
serotype N
 174 CL31/83=Richard 4.82=CDC G367 Urine; Strasbourg, France
 175 CL30/83=Richard 7.82=CDC G368 Urine; Strasbourg, France
 176 CL29/83=Richard 3.82=CDC G369 Urine; Strasbourg, France
 177 CL28/83=Richard 2.82=CDC G370 Urine; Strasbourg, France
 178 CL300/82=Richard 17.82=CDC G371 Catheter; Grenoble, France
 179 CL299/82=Richard 16.82=CDC G372 Catheter; Grenoble, France
 180 CL172/82=Richard 1.82=CDC G373 Vagina; Bordeaux, France
 181 CL170/82=Richard 24.81=CDC G374 Urine; Strasbourg, France
 182 CL168/82=Richard 20.81=CDC G375 Indwelling catheter; Grenoble, France
 184 CL67/82=Richard 24.81=CDC G377 Urine; Strasbourg, France
 185 CL66/82=Richard 23.81=CDC G378 Urine; Strasbourg, France
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Strain Other strain designation(s) Source
 186 CL64/82=Richard 21.81=CDC G379 Urine; Strasbourg, France
 187 CL61/82=Richard 18.81=CDC G380 Blood; Grenoble, France
 188 CL55/82=Richard 3.81=CDC G381 Wound; Leuven, Belgium
 189 CL54/82=Richard 2.81=CDC G382 Sputum; Strasbourg, France
 192 CL63/82=Richard 20.81=CDC G390 Vagina; Strasbourg, France
 193 CL65/82=Richard 22.81=CDC G391 Urine; Strasbourg, France
 194 CL171/82=Richard 26.81=CDC G392 Urine; Strasbourg, France
 195 CL294/82=Richard 1.82=CDC G393 Vaginal discharge; Annecy, France
 196 CL60/82=Richard 14.81=CDC G395 Urine; Strasbourg, France
 199 CDC F6535 Vaginal discharge; USA
 200 CDC F6236 Cat bite; USA
 202 CDC F2617 Vagina; USA
 205 CDC F4121 Blood; USA
 216 CDC group IIh CL715/92=CDC E8860 Wound; Alaska, USA
 243 CDC G2308 Blood; Oxford, UK
93 group (12)
 93 CL311/80=A16/80=CDC G79 Calf; Midlothian, Scotland, UK
 90 CL310/80=A15/80=CDC G68 Calf; Midlothian, Scotland, UK
 100 CL604/80=McMeekin U31=CDC G100 Chiller water, poultry processing plant; Hobart, 
Australia
 102 CL393/77=A49/77=CDC G102 Sputum; London, UK
 206 CDC group IIe-like CL721/92=CDC F9646 Brain biopsy; Pennsylvania, USA
 218 CDC group IIe CL717/92=CDC F7492 Eye lid; Tennessee, USA
 219 CDC group IIe CDC F3444 Sacral abscess; California, USA
 223 CDC group IIe CDC F5718 Tissue at base of meninges; North Carolina, USA
 225 CDC group IIe? CL718/92=CDC F1106 Genito-urinary tract; Washington, USA
 226 CDC group IIe? CL719/92=CDC F3670 Blood; Washington, USA
 236 CDC group IIe CL720/92=CDC F4391 Lung; Indiana, USA
 237 CDC group IIe CDC F6223 Blood; Georgia, USA
142 group (6)
 142T CL318/82T=CDC G229T=NCTC 
13530T=CCUG 60564T
Sputum; Doncaster, UK
 66 CL314/73=CDC F9968 Tongue swab; London, UK
 79 CL144/74=CDC G42 Sputum; London, UK
 146 CL229/85=CDC G233 Blood; Brighton, UK
 147 CL126/81=CDC G234 Finger abscess; Melbourne, Australia
 150 CL303/84=CDC G237 Sputum; London, UK
224 group (19)
 224 CDC group IIc CDC F5649 Testicle; Iowa, USA
 104 CL195/76 Blood culture; London, UK
 105 CL184/75 Pleural aspirate; Sydney, Australia
 107 CL187/75 Urine; Sydney, Australia
 108 CL373/79 Blood culture; Zurich, Switzerland
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Strain Other strain designation(s) Source
 109 CL205/78 Blood culture; Westcliff-on-Sea, UK
 119 CL309/73 Blood culture; Birmingham, UK
 120 CL524/73 Eye swab; Maidstone, UK
 121 CL263/70=F144 Dialysis fluid; London, UK
 155 CL445/80 Blood culture; London, UK
 197 CL213/83 Eye swab; London, UK
 201 CDC group IIc CL709/92=CDC F8989 Eye; USA
 203 CDC group IIh CDC F4158 Eye; USA
 214 CDC group IIh CDC E7070 Blood; Florida, USA
 227 CDC group IIc CDC F1636 Blood; Miami, USA
 229 CDC group IIc CDC F3248 Wound; Texas, USA
 232 CDC group IIc CDC E6607 Urine; South Carolina, USA
 239 CDC group IIc CDC F283 Ear; Massachusetts, USA
 241 CDC group IIc CL710/92=CDC F7390 Leg ulcer; Rhode Island, USA
212 group (4)
 212 CDC group IIc CL712/92=CDC F9257 Blood; Florida, USA
 209 CDC group IIe CL711/92=CDC F6666 Wound; Rhode Island, USA
 213 CDC group IIe CL713/92=CDC G134 Wound; California, USA
 221 CDC group IIe CDC F4031 CSF; Scotland, UK
217 group (2)
 217 CDC group IIi-like CL716/92=CDC F859 Toe; Kansas, USA
 233 CDC group IIi CDC E6284 Urine; Hawaii, USA
231 group (2)
 231 CDC group IIi CDC E8371 Urethra; Guam
 215 CDC group IIi CL714/92=CDC F715 Hand wound; Puerto Rico
255 group (6) ([E. meningoseptica] UB group II: 3)
 255 NCTC 11306=CIP 79.05=CDC G4075 Blood culture; Strasbourg, France; F. 
meningosepticum serotype H
 111 CL496/75=CDC G146 Blood culture; Margate, UK
 113 CL289/76=CDC G152 Unknown; Zurich, Switzerland
 114 CL614/77=CDC G153 Urine; Dublin, Ireland
 252 CL498/73=CDC G4072 Eye, keratitis; East Grinstead, UK
 253 CL153/79=CDC G4073 Pyosalpinx; Worcester, UK
245 group (5) ([E. meningoseptica] UB group II: 1)
 245 ATCC 13254=NCTC 10585=CDC 422 Blood; Florida, USA; F. meningosepticum serotype 
B
 246 ATCC 13255=NCTC 10586=CDC 3375 Spinal fluid and throat; South Carolina, USA; F. 
meningosepticum serotype C
 247 Ursing & Bruun 267=CDC E6809 Blood; California, USA
 248 Ursing & Bruun 265=CDC F3543 CSF; Florida, USA
 249 Ursing & Bruun 266=CDC F3201 CSF; Kuwait
251 group (3) ([E. meningoseptica] UB group II:2)
 251 NCTC 11305=CIP 78.30=CDC G4071 Tracheal exudate; Strasbourg, France; F. 
meningosepticum serotype G
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Strain Other strain designation(s) Source
 254 CL281/73=CDC G4074 Suction water; Reading, UK
 258 Ursing & Bruun 238=CCUG 12664 =CDC 
G4121
Water; Sweden
Elizabethkingia meningoseptica UB group I (3)
 244T ATCC 13253T=NCTC 10016T=CDC 14T Spinal fluid; Massachusetts, USA
 256 NCTC 13393=F8=E847=Greaves F2 =CDC 
G4076
Eye, conjunctivitis; Nottingham, UK
 257 Ursing & Bruun 248=C. Richard 3.83 =CDC 
G4120
Urine; France
63 group (2)
 63T NCTC 11390T=CDC KC1864T=CCUG 
60566T=A140/68T=F68T
Milk bottle rinse, farm; Paisley, Scotland, UK
 128 A139/68=CDC G197 As above
71 group (3)
 71 CL479/77=CDC F9973 Post-mortem lung; London, UK
 69 CL12/79=A53/70=F131=CDC F9971 Sputum; Leicester, UK
 148 CL542/79=CDC G235 Green lizard; London, UK
78 group (2)
 78T NCTC 13529T=CCUG 60563T=F91T =CDC 
G41T
Kidney abscess; Gloucester, UK
 117 CL192/74=CDC G162 Urine; Newcastle-upon-Tyne, UK
92 group (2)
 92 ATCC 14234=F151=CL91/74=CDC G70 Unknown
 97 CL94/78=Hayes P9/2=CDC G83 Pig carcass; unknown
95 group (2)
 95T CL88/78T=Hayes B19/1T=CDC G81T =NCTC 
13525T=CCUG 60559T
Beef; unknown
 101 CL89/78=Hayes C8/1=CDC G101 Chicken; unknown
123 group (2)
 123 A86/68=CDC G186 Human unspecified; London, UK
 153 CL278/82=CDC G240 Urine; Darlington, UK
125 group (2)
 125 A104/68=CDC G188 Milk swab, farm; Paisley, Scotland, UK
 64 A103/68=CDC F9942 As above
137 group (2)
 137 CL636/74=CDC G208 Peritoneal pus; Preston, UK
 204 CDC F4188 Wound; unknown
259 group (3) ([E. meningoseptica] UB group II: 4)
 259 Ursing & Bruun 2=H. Olsen 1=J100 =CDC 
G4122
Soil; Denmark
 250 CL681/77=CDC G4070 Sputum; Melbourne, Australia
 260 Ursing & Bruun 196=AB1572=CDC G4123 Lung (autopsy); Denmark
ATCC, American Type Culture Collection, Manassas, VA, USA; CDC, Centers for Disease Control, Atlanta, GA, USA. UB, Ursing and Bruun.
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Table 7
Summary of disposition of the various groups studied
Group in Table 1 Species name in publication Representative strain Provisional CDC group(s)
58 group (48 strains) W. falsenii genomovar 2 CDC KC1862 None (47), IIh (1)
63 group (2) C. lactis sp. nov. CDC KC1864T None (2)
71 group (3) ‘C. gleum-like species 1’ CDC F9973 None (3)
78 group (2) C. nakagawai sp. nov. CDC G41T None (2)
92 group (2) ‘E. brevis-like species 1’ CDC G70 None (2)
93 group (12) C. anthropi CDC G79 None (4), IIe (5), IIe? (2), IIe-like (1)
95 group (2) C. carnis sp. nov. CDC G81T None (2)
123 group (2) C. ureilyticum CDC G186 None (2)
125 group (2) C. shigense CDC G188 None (2)
137 group (2) F. lindanitolerans CDC G208 None (2)
142 group (6) C. bernardetii sp. nov. CDC G229T None (6)
212 group (4) C. taklimakanense comb. 
nov.
CDC F9257 IIc (1), IIe (3)
217 group (2) S. lactis CDC F859 IIi (1), IIi-like (1)
224 group (19) C. hominis CDC F5649 None (10), IIc (7), IIh (2)
231 group (2) S. daejeonense CDC E8371 IIi (2)
245 group (5) ([E. meningoseptica] UB 
group II: 1)
E. meningoseptica 
genomosp. 1
CDC 422 None (5)
251 group (3) ([E. meningoseptica] UB 
group II: 2)
E. meningoseptica 
genomosp. 2
CDC G4071 None (3)
255 group (6) ([E. meningoseptica] UB 
group II: 3)
E. meningoseptica 
genomosp. 3
CDC G4075 None (6)
259 group (3) ([E. meningoseptica] UB 
group II: 4)
E. meningoseptica 
genomosp. 4
CDC G4122 None (3)
C. balustinum (1) None (1)
C. gleum (2) None (2)
C. indologenes (16) None (16)
C. indoltheticum (3) None (3)
244 group (3) (E. meningoseptica UB 
group I)
None (3)
Empedobacter brevis (15) None (15)
Distinct groups, each represented by a 
single strain (15)
None (9), IIc (1), IIc? (1), IIe? (1), IIh 
(1), IIh? (1), IIi (1)
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Table 11
Phenotypic characteristics useful for the differentiation of C. carnis sp. nov. (95 group) 
from its nearest neighbours
Taxa: 1, C. carnis sp. nov.; 2, Chryseobacterium (Sejongia) antarcticum NCTC 13489T; 3, Chryseobacterium 
(Sejongia) jeonii NCTC 13459T; 4, Chryseobacterium (Sejongia) marinum (data from Lee et al., 2007). Data 
are from this study unless indicated. +, All strains positive; −, all strains negative; ND, no data available. 
Kämpfer et al. (2009a) proposed that Sejongia species be transferred to Chryseobacterium, a proposal 
supported in this study.
Characteristic 1 2 3 4
Acid in ASS medium from:
 Glucose + − − ND
 Maltose + − − ND
Growth at/on:
 37 °C + − − −
 MacConkey agar + − − ND
 β-Hydroxybutyrate + − − ND
Hydrolysis of:
 Aesculin − + + +
 Starch + + − ND
 Tween 20 + + − ND
Nitrate reduction − + − ND
Oxidase production + + + −
Casein digestion + − − ND
DNase production + − − ND
Gelatin liquefaction + − + ND
*
Positive after 5 days of incubation.
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